Related Experiment Video
Updated: Jun 27, 2026
06:26
Synthesis of Stimuli-responsive Nanogels using Aqueous One-step Crosslinking and Co-nanopolymerization
Published on: January 24, 2025
[Introduction to biological drugs].
E Fernández-Cruz1, D Alecsandru, C Rodríguez-Sainz
1Servicio de Inmunología Clínica, Hospital General Universitario Gregorio Marañón, Madrid, España. efernandezc.hgugm@salud.madrid.org
Actas Dermo-Sifiliograficas
|December 17, 2008
Summary
Biological therapies offer improved treatments for chronic immune system disorders. These targeted biological drugs provide greater efficacy and tolerability compared to traditional long-term treatments.
Area of Science:
- Immunology
- Pharmacology
- Rheumatology
Background:
- Chronic systemic diseases often involve immune system dysfunction.
- Traditional long-term drug treatments can lead to adverse reactions and limited efficacy.
- Recent advancements have introduced targeted biological therapies.
Purpose of the Study:
- To provide an updated overview of biological agents in clinical practice.
- To highlight the importance of biological therapies in managing chronic inflammatory diseases.
- To review the efficacy and tolerability of novel biological treatments.
Main Methods:
- Review of current literature on biological therapies.
- Analysis of clinical practice data for immunologically based inflammatory diseases.
- Synthesis of information on specific biological agents and their targets.
Main Results:
- Biological therapies have significantly improved treatment outcomes.
- These therapies demonstrate enhanced efficacy, rapid action, and better tolerability.
- Targeted biological agents address specific inflammatory and immunopathological pathways.
Conclusions:
- Biological therapies represent a revolution in managing chronic inflammatory diseases.
- They offer superior alternatives to conventional treatments with fewer side effects.
- Continued research and application of biological agents are crucial for patient management.
More Related Videos
Related Concept Videos
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:24Principles of Drug Action
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
01:28Biopharmaceutics and Pharmacokinetics: Overview
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the appropriate...
01:16Drug Biotransformation: Overview
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
01:28Drug Biotransformation: Overview
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
01:30Prodrugs
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...